Prediction of Prognosis, Immunotherapy and Chemotherapy with an Immune-Related Risk Score Model for Endometrial Cancer
Open Access
Abstract
Endometrial cancer (EC) is the most common gynecologic cancer. The overall survival remains unsatisfying due to the lack of effective treatment screening approaches. Immunotherapy as a promising therapy has been applied for EC treatment, but still fails in many cases. Therefore, there is a strong need to optimize the screening approach for clinical treatment. In this study, we employed co-expression network (GCN) analysis to mine immune-related GCN modules and key genes and further constructed an immune-related risk score model (IRSM). The IRSM was proved effective as an independent predictor of poor prognosis. The roles of IRSM-related genes in EC were confirmed by IHC. The molecular basis, tumor immune microenvironment and clinical characteristics of the IRSM were revealed. Moreover, the IRSM effectiveness was associated with immunotherapy and chemotherapy. Patients in the low-risk group were more sensitive to immunotherapy and chemotherapy than those in the high-risk group. Interestingly, the patients responding to immunotherapy were also more sensitive to chemotherapy. Overall, we developed an IRSM which could be used to predict the prognosis, immunotherapy response and chemotherapy sensitivity of EC patients. Our analysis not only improves the treatment of EC but also offers targets for personalized therapeutic interventions.Keywords
Funding Information
- National Natural Science Foundation of China (32100530, CSTB2022BSXM-JCX0065, KJQN202200455)
- Natural Science Foundation of Chongqing, China (32100530, CSTB2022BSXM-JCX0065, KJQN202200455)
- the Science and Technology Research Program of Chongqing Municipal Education Commission (32100530, CSTB2022BSXM-JCX0065, KJQN202200455)
This publication has 86 references indexed in Scilit:
- Inferring tumour purity and stromal and immune cell admixture from expression dataNature Communications, 2013
- Genomics of Drug Sensitivity in Cancer (GDSC): a resource for therapeutic biomarker discovery in cancer cellsNucleic Acids Research, 2012
- PD-1 Blockade Enhances T-cell Migration to Tumors by Elevating IFN-γ Inducible ChemokinesCancer Research, 2012
- GENCODE: The reference human genome annotation for The ENCODE ProjectGenome Research, 2012
- clusterProfiler: an R Package for Comparing Biological Themes Among Gene ClustersOMICS: A Journal of Integrative Biology, 2012
- Adjuvant chemotherapy for endometrial cancer after hysterectomyCochrane Database of Systematic Reviews, 2011
- Resistance to chemotherapy and hormone therapy in endometrial cancerEndocrine-Related Cancer, 2009
- WGCNA: an R package for weighted correlation network analysisBMC Bioinformatics, 2008
- Molecular mechanisms for the assembly of the T cell receptor–CD3 complexMolecular Immunology, 2004
- Interleukin-2 receptor γ chain mutation results in X-linked severe combined immunodeficiency in humansCell, 1993